Aldeyra therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Aldeyra therapeutics Contact Number

For more information, please contact us. Aldeyra Therapeutics 131 Hartwell Avenue, Suite 320 Lexington, MA 02421. Telephone: (781) 761-4904 Fax: (339) 674-6495

Contact US: https://www.aldeyra.com/contact/

Where is aldeyra therapy located?

Aldeyra Therapeutics. 131 Hartwell Avenue, Suite 320. Lexington, MA 02421. Telephone: (781) 761-4904. Fax: (339) 674-6495. Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases.

What does edwardyra therapeutics mean?

Aldeyra Therapeutics, Inc. is a biotechnology company devoted to improving lives by inventing, developing, and commercializing next-generation medicines that treat immune-mediated diseases.

What does aldeyra mean?

At Aldeyra, we’re a pioneer in the development of medicines to improve the lives of patients with immune-mediated diseases. Our pipeline of drug candidates is focused on inhibiting inflammatory cells linked to ocular and systemic conditions not adequately addressed by current treatments.

What are the three mechanisms of action of aldeyra?

At Aldeyra, we are building a proprietary pipeline focused on three distinct mechanisms of action: Reactive Aldehyde Species (RASP) inhibition, Dihydrofolate Reductase (DHFR) inhibition, and Chaperome (CHP) inhibitors to target immune-mediated ocular diseases and select systemic conditions.

Results

26 People Used

See More ››

Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics Schedules Webcast and Conference Call to Report First-Quarter 2021 Financial Results and Discuss Recent Business Highlights Learn More April 28, 2021

View Contact ››

Phone

63 People Used

See More ››

Aldeyra Therapeutics

Phone Number (646) 536-7009 Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases.

View Contact ››

Aldeyra

34 People Used

See More ››

About Aldeyra Therapeutics Aldeyra Pharmaceuticals, Inc.

Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra’s lead investigational drug product candidates are potential first-in-class treatments in development for dry eye disease, allergic conjunctivitis, and

View Contact ››

Aldeyra

49 People Used

See More ››

Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc. September 18, 2020 ·. We’re proud to have been a finalist for the #CitelineAwards Clinical Trial Result of the Year for our allergen chamber clinical methods trial of reproxalap in allergic conjunctivitis. Reproxalap is the first RASP (reactive aldehyde species) inhibitor to demonstrate an immune-modulating effect

View Contact ››

Brady

47 People Used

See More ››

Leadership Aldeyra Therapeutics Inc.

Prior to Aldeyra, Dr. Brady served as Entrepreneur in Residence at Domain Associates, LLC, a leading healthcare venture capital firm, where he was a Principal from 2004 to 2013. Dr. Brady currently serves on the board of directors of Evoke Pharma, Inc. and F-star Therapeutics, Inc., both of which are publicly traded healthcare companies.

View Contact ››

Science

39 People Used

See More ››

Careers Aldeyra Therapeutics Inc.

At Aldeyra, our focus is the development of next-generation medicines to improve the lives of patients with immune-mediated ocular and systemic diseases. Interested in joining our dynamic and growing team? If you share our drive for excellence and our passion for science, we’d love to talk to you! We are hiring for the following positions:

View Contact ››

Corporate

92 People Used

See More ››

Aldeyra Therapeutics Reports Full Year 2020 Financial

Corporate Contact: Joshua Reed Aldeyra Therapeutics, Inc. Tel: 781-761-4904 ext. 218 “It’s a very controllable number so if our performance weakens we can take it right down again,” he

View Contact ››

Aldeyra

154 People Used

See More ››

Aldeyra Therapeutics Reports Full Year 2020 Financial

Aldeyra will host a conference call at 8:00 a.m. ET today to discuss its full-year 2020 financial results. The dial-in numbers are (866) 211-4098

View Contact ››

Clinical

57 People Used

See More ››

Pipeline + Disease Areas Aldeyra Therapeutics Inc.

Pipeline. Aldeyra is dedicated to improving the lives of patients suffering from immune-mediated ocular and systemic diseases. We are advancing a broad pipeline of product candidates diversified by chemical composition, mechanism of action, and clinical indication. Our clinical pipeline encompasses three distinct biological mechanisms of action

View Contact ››

LEXINGTON

34 People Used

See More ››

Investor Relations Aldeyra Therapeutics, Inc.

LEXINGTON, Mass. --(BUSINESS WIRE)--Apr. 29, 2021-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, May 6, 2021 to report financial results for the quarter ended March …

View Contact ››

Business

52 People Used

See More ››

Stock Information Aldeyra Therapeutics, Inc.

The Investor Relations website contains information about Aldeyra Therapeutics, Inc.''s business for stockholders, potential investors, and financial analysts.

View Contact ››

March

97 People Used

See More ››

Aldeyra Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 11, 2021 / Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 11

View Contact ››

Contact

149 People Used

See More ››

Aldeyra Therapeutics, Inc. Announces Pricing of Public

Contacts. Corporate Contact: David McMullin Aldeyra Therapeutics, Inc. Tel: 781-761-4904 ext. 218 [email protected]aldeyra.com Investor & Media Contact: Scott Solomon Sharon Merrill Associates, Inc. Tel

View Contact ››

Contact

110 People Used

See More ››

Aldeyra Therapeutics Schedules Webcast and Conference Call

The Conference ID number is 6779202. Corporate Contact: Joshua Reed Aldeyra Therapeutics, Inc. Tel: 781-761-4904 ext. 218 [email protected]aldeyra.com. Investor & Media Contact: Scott Solomon

View Contact ››

Please leave your comments here:

Popular Brands

Amazon
Asml
Abbvie
Acc
Apple
Att
Abb
Amd
Aes
Alfen